Cepheid

United States
Clarkdale, Arizona, United States, 94089

Company profile

Cepheid company profile

Cepheid is a molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer.

Business identity

Phone number
4085416439
Operating status
Active
Company type
For Profit
Revenue range
$10M-$100M
Founded
1996-01-01, Year

Headquarters

Postal code
94089
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
7
Total equity funding
$27.1M
Last funding
Grant / $63.8M / 2021-10-22
Last equity funding
Post IPO Equity / $3.3M
Investors
5
Lead investors
3
Founders
3
Articles
481
Exited on
2000-06-21

Founders and investors

Founders

Allen NorthrupDennis H. GiesingSteve Young

Lead investors

Biomedical Advanced Research and Development Authority (BARDA)InnogeneticsWheatley Partners

Investors

Biomedical Advanced Research and Development Authority (BARDA)InnogeneticsU.S. Department of DefenseU.S. Department of Health & Human ServicesWheatley Partners